logo
  • Home
  • Applications
    • Indications
  • Business
  • EpiSwitch™
  • Products
    • EpiSwitch™ Service
  • Investors
    • Investors Overview
    • Results and Presentations
    • Share Price Information
    • Regulatory News
    • Board & Governance
    • Key Corporate Documents
    • AIM Rule 26
    • Email Alerts
    • Investor Contacts
  • News
  • About Us
    • History
    • Board of Directors
    • Management Team
    • Scientific Advisory Panel
    • Values
    • Careers

Episwitch Publication

The Prospective Study of Epigenetic Regulatory Profiles in Sport and Exercise Monitored Through Chromosome Conformation Signatures

Genes 2020, 11(8), 905


by Aroul Ramadass

Comparative molecular cell-of-origin classification of diffuse large B-cell lymphoma based on liquid and tissue biopsies

Translational Medicine Communications volume 5, Article number: 5 (2020)


by Aroul Ramadass

Development and validation of baseline predictive biomarkers for response to immuno-checkpoint treatments in the context of multiline and multitherapy cohorts using EpiSwitch™ epigenetic profiling

SITC, J. Immunotherapy Cancer 7, 282 (2019) P143


by oxfordbiodynamics

Development and validation of baseline predictive biomarkers for response to avelumab in second-line (2L) non-small cell lung cancer(NSCLC) using EpiSwitch™ epigenetic profiling

SITC, J. Immunotherapy Cancer 7, 282 (2019) P142


by oxfordbiodynamics

Ectopic gene deregulations and chromosome conformations: integrating novel molecular testing into clinical applications, from leukemias to gliomas

Handbook of Biomarkers and Precision Medicine, 1st Edition


by Aroul Ramadass

Epigenetic chromatin conformation changes in peripheral blood can detect thyroid cancer.

Surgery (2018) Oct 27. pii: S0039-6060(18)30622-6


by Aroul Ramadass

Genomic architecture differences at the HTT locus underlie symptomatic and pre-symptomatic cases of Huntington’s disease.

F1000Research (2018), 7:1757


by Aroul Ramadass

Initial Identification of a Blood-Based Chromosome Conformation Signature for Aiding in the Diagnosis of Amyotrophic Lateral Sclerosis.

EBioMedicine (2018) Volume 33, Pages 169–184


by Aroul Ramadass

The Chromosomal Conformation Signature: A New Kid on the Block in ALS Biomarker Research?

EBioMedicine (2018) Volume 33, Pages 6–7


by Aroul Ramadass

Chromosome conformation signatures as a clinical tool for diagnosis, prognosis and disease understanding in ALS

ENCALS (2018) 20-22 June, Oxford, UK.


by Aroul Ramadass

  • 1
  • 2
  • 3
  • 4

Terms of Use / Site Map / Privacy Policy / Cookies Policy

Regulated and Licensed by Human Tissue Authority
License No. 12571
© 2002-2020 Oxford Biodynamics Plc

Privacy Preference Center

Privacy Preferences

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with this.OkRead more